Skip to main content
logo
Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.210
-0.090 (-2.73%)
Oct 26, 2026, 3:13 PM EDT - Market open

Camp4 Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
4.223.50.650.35-
Revenue Growth
40.21%436.50%86.29%--
Gross Profit
-34.47-34.7-38.17-40.27-34.1
Operating Income
-52.38-52.06-53.09-51.88-45
Net Income
-107.24-80.4-51.79-49.29-44.19
Earnings Per Share
-2.18-2.65-11.04-124.79-141.51
EPS Growth
-----

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
86.4109.5264.0438.3883.19
Total Debt
2.3728.6612.1812.4
Net Cash (Debt)
84.03107.5255.3826.270.8
Net Cash Growth
163.97%94.16%111.38%-63.00%-
Net Cash Per Share
1.713.5411.8166.33226.69

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-28.59-29.55-45.56-44.16-38.54
Capital Expenditures
-0.13-0.28-0.44-0.68-4.03
Free Cash Flow
-28.72-29.83-46-44.83-42.57
Free Cash Flow Growth
-----

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Margin
-1242.51%-1488.31%-8142.33%-14822.57%-
Pretax Margin
-2543.74%-2298.54%-7943.40%-14083.14%-
Profit Margin
-2543.74%-2298.54%-7943.40%-14083.14%-
FCF Margin
-681.21%-852.83%-7055.67%-12809.43%-

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
47.9390.92161.17--